Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...
Hosted on MSN9h
Drugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher saysDoctor Jeffrey Cummings is world-renowned in the field of Alzheimer's research and he leads UNLV's Center for Transformative Neuroscience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback